Beam Therapeutics

(1 Reviews)
26 Landsdowne St, Cambridge, MA 02139, USA

(857) 327-8775


Contact and Address

Category: Health,
Address: 26 Landsdowne St, Cambridge, MA 02139, USA
Postal code: 02139
Phone: (857) 327-8775
Website: https://beamtx.com/

Location & routing

Get Directions

Most Recent Reviews


  • (September 13, 2019, 8:57 am)

    The best company I have had the pleasure of working with.

Write a Review


Beam Therapeutics On the Web

Beam Therapeutics Inc. (BEAM) Company Profile... - Yahoo Finance

BEAM - Beam Therapeutics Inc. NasdaqGS - NasdaqGS Real Time Price. Currency in USD. 26 Landsdowne Street 2nd Floor Cambridge, MA 02139 United States 857 327 8775 http Beam Therapeutics Inc.'s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A...


Laser Beam Therapeutics

Laser Beam Therapeutics Ltd. (LBT) is an Israeli based, life science and medical device company. We are a pioneer in the field of Low Level Laser Therapy (LLLT) for the treatment of cardiovascular indications as well as autoimmune and inflammatory diseases. Our patented, platform technology is...


Beam Therapeutics | FierceBiotech

Beam Therapeutics—co-founded by a trio of top-flight CRISPR researchers—is focusing on a technique known as base editing that ups the ante on CRISPR's precision by making it possible to find, remove and replace a single nucleotide base, or "letter," without affecting those surrounding it.


Gene Editing Startup Beam Therapeutics Launches... | GenomeWeb

NEW YORK (GenomeWeb) - Beam Therapeutics announced today that it has launched with $87 million in Series A funding to develop precision genetic medicines that make edits to individual base pairs in the genome. The funding round was led by F-Prime Capital Partners and ARCH Venture...


Xin Wang - Scientist - Beam Therapeutics Inc. | LinkedIn

Xin Wang. Scientist at Beam Therapeutics. Cambridge, Massachusetts305 connections. Scientist. Beam Therapeutics Inc. Dec 2018 - Present1 year 5 months.


Press release distribution, EDGAR filing, XBRL... | Business Wire

CAMBRIDGE, Mass.--( BUSINESS WIRE)--Magenta Therapeutics (Nasdaq: MGTA) and Beam Therapeutics (Nasdaq: BEAM) today announced a non-exclusive research and clinical collaboration agreement to evaluate... more ».


Pharmax news, pharmax jobs, event, medical information from across...

Beam Therapeutics is developing a new generation of CAR-T product candidates using its proprietary base editing. The post Beam Therapeutics licenses SIRION Biotech’s LentiBOOST Technology for its CAR-T pipeline appeared first on Pharmaceutical Business review.


TOBB ETÜ Email Formats & Employee Phones — Higher... | SignalHire

New & popular companies. B. Beam Therapeutics. C. Covenant Salt Company Limited.


GV - Home | Facebook

Forbes talks with GV general partner David Schenkein about Beam Therapeutics and the company's work to address genetic diseases - https The painful blood disorder, which mostly affects Black people, is just one of thousands of rare diseases that could be cured by Beam Therapeutics'...


Календарь Ipo На 2020 Год. Статистика И Результаты | Главинвестор

Beam Therapeutics. BEAM. Здравоохранение.